Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)
CNY 17.04
(-1.1%)
CNY 17.04
(-1.1%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.83 Million CNY | 116.45% |
| 2022 | -29.4 Million CNY | 57.89% |
| 2021 | -69.82 Million CNY | -49.09% |
| 2020 | -46.83 Million CNY | -645.92% |
| 2019 | 8.57 Million CNY | 109.44% |
| 2018 | -90.86 Million CNY | 69.14% |
| 2017 | -294.42 Million CNY | -479.59% |
| 2016 | -50.79 Million CNY | -263.75% |
| 2015 | -13.96 Million CNY | -8.68% |
| 2014 | -12.84 Million CNY | 1.01% |
| 2013 | -12.98 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -58.59 Million CNY | 55.4% |
| 2024 Q3 | -129.81 Million CNY | -121.54% |
| 2024 Q1 | -131.37 Million CNY | -2816.4% |
| 2023 Q1 | 17.22 Million CNY | 158.59% |
| 2023 Q2 | 54.14 Million CNY | 214.33% |
| 2023 Q4 | 4.83 Million CNY | 103.21% |
| 2023 Q3 | -150.84 Million CNY | -378.59% |
| 2023 FY | 4.83 Million CNY | 116.45% |
| 2022 Q1 | -142.05 Million CNY | -103.43% |
| 2022 Q2 | -27.68 Million CNY | 80.51% |
| 2022 Q3 | 118.53 Million CNY | 528.19% |
| 2022 Q4 | -29.4 Million CNY | -124.81% |
| 2022 FY | -29.4 Million CNY | 57.89% |
| 2021 Q2 | 35.9 Million CNY | 193.9% |
| 2021 Q4 | -69.82 Million CNY | -350.97% |
| 2021 Q3 | 27.82 Million CNY | -22.5% |
| 2021 FY | -69.82 Million CNY | -49.09% |
| 2021 Q1 | -38.23 Million CNY | 18.36% |
| 2020 Q4 | -46.83 Million CNY | -94.65% |
| 2020 Q3 | -24.06 Million CNY | -47.23% |
| 2020 Q1 | 16.25 Million CNY | 89.52% |
| 2020 FY | -46.83 Million CNY | -645.92% |
| 2020 Q2 | -16.34 Million CNY | -200.51% |
| 2019 FY | 8.57 Million CNY | 109.44% |
| 2019 Q3 | 39.58 Million CNY | 2650.02% |
| 2019 Q2 | 1.43 Million CNY | 111.88% |
| 2019 Q1 | -12.11 Million CNY | 86.67% |
| 2019 Q4 | 8.57 Million CNY | -78.33% |
| 2018 Q2 | -123.74 Million CNY | 45.46% |
| 2018 Q3 | -127.96 Million CNY | -3.42% |
| 2018 Q4 | -90.86 Million CNY | 28.99% |
| 2018 FY | -90.86 Million CNY | 69.14% |
| 2018 Q1 | -226.89 Million CNY | 22.94% |
| 2017 Q4 | -294.42 Million CNY | 5.32% |
| 2017 FY | -294.42 Million CNY | -479.59% |
| 2017 Q1 | 70.79 Million CNY | 239.37% |
| 2017 Q3 | -310.96 Million CNY | -905.16% |
| 2017 Q2 | -30.93 Million CNY | -143.7% |
| 2016 Q1 | -26.64 Million CNY | -90.78% |
| 2016 Q3 | 50.79 Million CNY | 570.4% |
| 2016 Q2 | -10.79 Million CNY | 59.47% |
| 2016 Q4 | -50.79 Million CNY | -200.0% |
| 2016 FY | -50.79 Million CNY | -263.75% |
| 2015 Q2 | -6.48 Million CNY | 0.0% |
| 2015 FY | -13.96 Million CNY | -8.68% |
| 2015 Q4 | -13.96 Million CNY | 0.0% |
| 2015 Q3 | -13.96 Million CNY | -115.36% |
| 2015 Q1 | -6.48 Million CNY | 49.53% |
| 2014 Q1 | 42.98 Million CNY | 0.0% |
| 2014 Q4 | -12.84 Million CNY | 0.0% |
| 2014 Q3 | -12.84 Million CNY | 0.0% |
| 2014 FY | -12.84 Million CNY | 1.01% |
| 2013 FY | -12.98 Million CNY | 0.0% |